LEADLESS NEUROMODULATION OF THE ADRENAL GLAND
First Claim
Patent Images
1. An implantable medical device comprising:
- a leadless body portion;
a mechanical attachment structure arranged with the leadless body portion and configured to engage an adrenal gland or periadrenal connective tissue of a patient; and
at least one electrode arranged with the leadless body portion and configured to deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland.
2 Assignments
0 Petitions
Accused Products
Abstract
Aspects of the present disclosure are directed towards apparatuses, systems, and methods that include at least one implantable medical device. The implantable medical device may include a leadless body portion configured to engage an adrenal gland of a patient and at least one electrode, arranged within the leadless body portion, configured to deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland.
5 Citations
20 Claims
-
1. An implantable medical device comprising:
-
a leadless body portion; a mechanical attachment structure arranged with the leadless body portion and configured to engage an adrenal gland or periadrenal connective tissue of a patient; and at least one electrode arranged with the leadless body portion and configured to deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
-
11. An adrenal gland stimulation system comprising:
an implantable leadless device configured to deliver electrostimulation therapy to a patient, the implantable leadless device comprising; a body portion, a mechanical attachment structure arranged with the leadless body portion and configured to engage an adrenal gland or periadrenal connective tissue of the patient, at least one electrode arranged with the body portion and configured to deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland, and a physiological sensor configured to measure at least one physiological parameter, and alter the stimulation energy in response thereto. - View Dependent Claims (12, 13, 14, 15)
-
16. A method of delivering therapy to an adrenal gland of a patient, the method comprising:
-
delivering a leadless implantable medical device to the adrenal gland, the leadless implantable medical device including a mechanical attachment structure; attaching a leadless implantable medical device to an adrenal gland or periadrenal connective tissue via the mechanical attachment structure; and delivering stimulation energy through at least one of a plurality of electrodes leadless implantable medical device to modulate catecholamine release from chromaffin cells within the adrenal gland. - View Dependent Claims (17, 18, 19, 20)
-
Specification